Preventive Medicine
July 6, 2012
Mayo Clinic in the News Weekly Highlights
July 6, 2012 Mayo Clinic in the News is a weekly highlight summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations New […]
Tags: Academy Health Annual Research Meeting, David Claypool, Dr. Rafael Fonseca, Hematologic Malignancies Program, Huffington Post, Huffington Post Canada, KAAL, Mall of America, mammograms, Matthew Sztajnkrycer, Mayo Clinic Cancer Center, Mayo Clinic Center for the Science of Health Care Delivery
June 29, 2012
Mayo Clinic in the News Weekly Highlights
June 29, 2012 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations NPR […]
Tags: arthritis, CBS, Dr. Edward Laskowski, Dr. Eric Matteson, Dr. James Levine, Dr. Richard Hurt, Dr. Thomas Boyce, heart disease, Mayo Clinic Children's Center, Mayo Clinic's Sports Medicine Center, nicotine addiction, NPR
June 21, 2012
Mayo Clinic in the News Weekly Highlights
June 21, 2012 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations NY […]
Tags: alzheimer's disease, American Society of Clinical Oncology, Center for Medicare and Medicaid Innovation, Chemotherapy, Chicago Tribune, Dr. James A. Levine, Dr. John Black, Dr. John Noseworthy, Esther H. Krych, Florida Times-Union, ginseng, government funding
June 19, 2012
For Some Skin Cancers, Targeted Drug Hits the Mark
Modified dosing schedules may limit the side effects and are being investigated, noted Dr. Aleksandar Sekulic of the Mayo Clinic, who led the BCC study. In the phase II trial, 30 percent of patients with metastatic disease had a partial response, and 43 percent of patients with locally advanced disease had a complete or partial […]
Tags: complete response, dosing schedules, Dr. Aleksander Sekulic, NCI Bulletin, partial response
June 18, 2012
MNTX Opioid Improves Bowel Movement
As per a research, which has been published in the Mayo Clinic Proceedings, has found that methylnaltrexone (MNTX), a peripheral opioid is quite effective in treating bowel function in critically ill patients. The drug has been created by Dr. Jonathan Moss at the University of Chicago. It seems that the drug has proved its efficacy […]
Tags: constipation, Dr. Jonathan Moss, Mayo Clinic Proceedings, methylnaltrexone, University of Chicago
June 12, 2012
Statins May Leave Patients With Less Energy: Study
Tatins — the popular class of cholesterol-lowering drugs — significantly increase the risk of experiencing a drop in energy or becoming unduly tired when exercising, according to new research. The finding stems from work tracking about 1,000 adults, and includes well-known shelf names Pravachol and Zocor, both designed to reduce levels of the so-called “bad” […]
Tags: cholesterol, Dr. Scott Wright, Health Day, tatins
June 11, 2012
New Drug Can Fight Inherited Skin Cancer
There is a new drug to fight skin cancer for the sun-splashed masses of Arizona. The drug, vismodegib, was approved by the Food and Drug Administration in January for people with an advanced form of one type of skin cancer, basal-cell carcinoma. New research unveiled last week by local doctors and other scientists shows that […]
Tags: Aleksander Sekulic, Arizona Republic, carcinoma, Food and Drug Administration, New England Journal of Medicine, skin cancer
June 4, 2012
ASCO 2012 Multiple Myeloma Update – Day Three: New Myeloma Treatments
One of the morning presentations was given by Dr. Melissa Alsina from the H. Lee Moffitt Cancer Center in Tampa, Florida. Dr. Alsina presented a Phase 2 study of panobinostat in combination with Velcade (bortezomib) and dexamethasone (Decadron)… The panobinostat trial results were reviewed by Dr. Asher Chanan-Khan of the Mayo Clinic in Jacksonville, Florida, in […]
Tags: Dr. Asher Chanan-Khan, Dr. Melissa Alsina, H. Lee Moffitt Cancer Center, multiple myeloma, Myeloma Beacon
June 1, 2012
New Class of Cancer Drugs May Be Less Toxic
The experimental treatment, called T-DM1, is a harbinger of a new class of cancer drugs that may be more effective and less toxic than many existing treatments. By harnessing antibodies to deliver toxic payloads to cancer cells, while largely sparing healthy cells, the drugs are a step toward the “magic bullets” against cancer first envisioned […]
Tags: Adcetris, American Society of Clinical Oncology, Dr. Edith Perez, experimental treatment, NY Times, Paul Ehrlich, Seattle Genetics
May 18, 2012
Mayo Clinic in the News Weekly Highlights
May 18, 2012 Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations oestreich.karl@mayo.edu […]
Tags: ABC News, alzheimer's disease, Chicago Sun-Times, Dr. Farris Timimi, Dr. James Kirkland, Dr. Lyle Joyce, Dr. Ronald Peterson, Dr. Sharonne Hayes, Dr. Thomas Boyce, Dr. Timothy Young, KAAL, KARE11